It has been shown that around 10–15% of epithelial ovarian cancer (EOC) patients carry germline mutation in BRCA1 or BRCA2 with the highest incidence seen with HGSE subtypes (Manchana et al., 2019). The gene discussed is BRCA2; the disease is ovarian carcinoma.